Literature DB >> 23446679

Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size.

Jeffrey M Statland1, Sabrina Sacconi, Constantine Farmakidis, Colleen M Donlin-Smith, Mina Chung, Rabi Tawil.   

Abstract

OBJECTIVE: To investigate the frequency of Coats syndrome and its association with D4Z4 contraction size in patients with facioscapulohumeral muscular dystrophy type 1 (FSHD1).
METHODS: We searched a North American FSHD registry and the University of Rochester (UR) FSHD research database, reviewed the literature, and sent surveys to 14 FSHD referral centers in the United States and overseas to identify patients with genetically confirmed FSHD1 with a diagnosis of Coats syndrome.
RESULTS: Out of 357 genetically confirmed patients in a North American FSHD registry and 51 patients in the UR database, 3 patients had a self-reported history of Coats disease (0.8%; 95% confidence interval 0.2%-2.2%). In total, we identified 14 patients with FSHD with known genetic contraction size and Coats syndrome confirmed by ophthalmologic examination: 10 from our survey and 4 from the literature. The median age at diagnosis of Coats syndrome was 10 years (interquartile range 14 years). The median D4Z4 fragment size was 13 kilobases (kb) (interquartile range 1 kb). One patient was mosaic (55% 11 kb, and 45% 78 kb).
CONCLUSIONS: Coats syndrome is a rare extramuscular complication of FSHD1 associated with large D4Z4 contractions. Closer surveillance for retinal complications is warranted in patients with D4Z4 fragments ≤15 kb.

Entities:  

Mesh:

Year:  2013        PMID: 23446679      PMCID: PMC3691782          DOI: 10.1212/WNL.0b013e3182897116

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Review: coats disease: the 2001 LuEsther T. Mertz lecture.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

2.  171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil; Silvere van der Maarel; George W Padberg; Baziel G M van Engelen
Journal:  Neuromuscul Disord       Date:  2010-07       Impact factor: 4.296

Review 3.  Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.

Authors:  Silvère M van der Maarel; Rabi Tawil; Stephen J Tapscott
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

4.  Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation.

Authors:  Laurence A Bindoff; Nanette Mjellem; Kristian Sommerfelt; Bård K Krossnes; Fiona Roberts; Jørgen Krohn; Randi Skarpaas Tranheim; Irene D Haggerty
Journal:  Neuromuscul Disord       Date:  2006-08-28       Impact factor: 4.296

5.  Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients.

Authors:  M Nakagawa; T Matsuzaki; I Higuchi; H Fukunaga; T Inui; S Nagamitsu; H Yamada; K Arimura; M Osame
Journal:  Intern Med       Date:  1997-05       Impact factor: 1.271

6.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  G W Padberg; O F Brouwer; R J de Keizer; G Dijkman; C Wijmenga; J J Grote; R R Frants
Journal:  Muscle Nerve Suppl       Date:  1995

7.  Bilateral Coats' response in a female patient leads to diagnosis of facioscapulohumeral muscular dystrophy.

Authors:  Sherry J Bass; Jerome Sherman; Vincent Giovinazzo
Journal:  Optometry       Date:  2010-12-04

8.  Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy.

Authors:  Anuradha Ganesh; Swathi Kaliki; Carol L Shields
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

9.  Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications.

Authors:  R B Fitzsimons; E B Gurwin; A C Bird
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

10.  Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy.

Authors:  M Funakoshi; K Goto; K Arahata
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

  10 in total
  22 in total

1.  Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.

Authors:  Rianne J M Goselink; Karlien Mul; Caroline R van Kernebeek; Richard J L F Lemmers; Silvère M van der Maarel; Tim H A Schreuder; Corrie E Erasmus; George W Padberg; Jeffrey M Statland; Nicol C Voermans; Baziel G M van Engelen
Journal:  Neurology       Date:  2018-12-19       Impact factor: 9.910

Review 2.  Facioscapulohumeral Muscular Dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Continuum (Minneap Minn)       Date:  2016-12

3.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

Review 4.  Facioscapulohumeral Dystrophy.

Authors:  Leo H Wang; Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

5.  Coats-like retinopathy in a Young Indian Rhesus Macaque (Macaca mulatta).

Authors:  David X Liu; Margaret H Gilbert; Xiaolei Wang; Peter J Didier; Carol L Shields; Andrew A Lackner
Journal:  J Med Primatol       Date:  2015-02-06       Impact factor: 0.667

6.  Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  Katie L Lutz; Lenore Holte; Stephanie A Kliethermes; Carrie Stephan; Katherine D Mathews
Journal:  Neurology       Date:  2013-09-16       Impact factor: 9.910

Review 7.  Facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey Statland; Rabi Tawil
Journal:  Neurol Clin       Date:  2014-05-15       Impact factor: 3.806

8.  Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.

Authors:  Jeffrey M Statland; Colleen M Donlin-Smith; Stephen J Tapscott; Richard J L F Lemmers; Silvère M van der Maarel; Rabi Tawil
Journal:  Neurology       Date:  2015-11-11       Impact factor: 9.910

Review 9.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.

Authors:  Johanna Hamel; Rabi Tawil
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 10.  Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.

Authors:  Amy E Campbell; Andrea E Belleville; Rebecca Resnick; Sean C Shadle; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.